Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


NeoSan Pharmaceuticals Inc.

Division of aaiPharma Inc./NeoSan Pharmaceuticals Inc.

Latest From NeoSan Pharmaceuticals Inc.

Schering-Plough, Novartis and Foradil: Measuring the Need for New Products

Schering's willingness to take over the marketing responsibilities for Novartis's Foradil respiratory drug, which has been largely superseded by combination products, to some degree measures the depths of Schering's troubles. But it also indicates the kinds of competition small-company in-licensers are likely to face. A whole industry of in-licensing focused players has grown up to sell the non-core products of Big Pharma: if Schering is any indication, the competition for these products is likely to get even more intense.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • aaiPharma Inc.
  • Senior Management
  • Richard St. Francis, VP, Fin. & Admin.
    Daniel T Gregory, VP, Mktg.
    Moray W Merchant, VP, Sales
    David Hurley, Pres.
  • Contact Info
  • NeoSan Pharmaceuticals Inc.
    Phone: (910) 254-7000
    2320 Scientific Park Dr.
    Wilmington, NC 28405